S'abonner

Variation in the Early Trajectories of Autism Symptoms Is Related to the Development of Language, Cognition, and Behavior Problems - 26/07/17

Doi : 10.1016/j.jaac.2017.05.022 
Janne C. Visser, MD a, , Nanda N.J. Rommelse, PhD a, b, Martijn Lappenschaar, MD, PhD d, Iris J. Servatius-Oosterling, PhD a, Corina U. Greven, PhD a, c, Jan K. Buitelaar, MD, PhD a, b
a Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands 
b Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Nijmegen 
c Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, and King's College London, Medical Research Council Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London 
d Radboud University, Nijmegen 

Correspondence to Janne C. Visser, MD, Karakter University Centre Reinier Postlaan 12 6525 GC Nijmegen, the NetherlandsKarakter University Centre Reinier Postlaan 12 6525 GC Nijmegenthe Netherlands

Abstract

Objective

The objectives of this study were to model more homogeneous subgroups within autism spectrum disorder (ASD) based on early trajectories of core symptoms; and to further characterize these subgroups in terms of trajectories of language, cognition, co-occurring (attention-deficit/hyperactivity disorder [ADHD]–related) traits and clinical outcome diagnosis.

Method

Children (N = 203) referred for possible ASD at ages 1 to 4 years were assessed at three time points at intervals ranging from 9 months to 3 years. Assessments included standardized measures for ASD (Autism Diagnostic Observation Schedule [ADOS]), language (ADOS-language item), nonverbal IQ (NV-IQ; different tests adequate to chronological/mental age), and parent-reported behavioral problems (Infant-Toddler Social and Emotional Assessment, Child Behavior Checklist).

Results

Latent-class growth curve analysis with ADOS total scores led to the identification of three main stable and two small improving groups: a severe–stable group (19.5% of sample)—the only group without considerable language improvement—showed persistent low NV-IQ and marked increase in attention problems over time; a moderate–stable group (21.7%) with below-average increasing NV-IQ; and a mild–stable group (48%) with stable–average NV-IQ and the highest scores on ADHD-related traits, whose ASD outcome diagnoses increased despite stable–low ASD scores. Two groups (each 5.4%) improved: one moved from severe to moderate ASD scores, and the other moved from moderate to mild/nonspectrum scores. Both of these groups improved on language, NV-IQ, and ADHD-related traits.

Conclusion

Results support the high stability of ASD symptoms into various severity levels, but also highlight the significant contribution of non-ASD domains in defining and explaining the different ASD trajectories.

Le texte complet de cet article est disponible en PDF.

Key words : autism spectrum disorder, latent-class trajectory, longitudinal, attention-deficit/hyperactivity disorder, attention


Plan


 This article is discussed in an editorial by Dr. Peter Szatmari on page 636.
 Clinical guidance is available at the end of this article.
 This study was supported by a grant from the Korczak Foundation. Dr. Buitelaar’s work for the current paper is supported by the European Community’s Seventh Framework Program (FP7/2007-2013) under grant agreement number 278948 (TACTICS), and the Innovative Medicines Initiative Joint Undertaking under grant agreement number 115300 (EU-AIMS), resources of which are composed of financial contribution from the European Union's Seventh Framework Program (FP7/2007 – 2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies' in kind contribution; and also from the European Community’s Horizon 2020 Program (H2020/2014 – 2020) under grant agreements number 643051 (MiND) and number 642996 (BRAINVIEW). In addition, he is supported by a grant for the ENIGMA Consortium (grant number U54 EB020403) from the BD2K Initiative of NIH.
 Dr. Lappenschaar served as the statistical expert for this research.
 Disclosure: Dr. Buitelaar has been a consultant to/member of the advisory board of/and/or speaker for Janssen Cilag BV, Medice, Novartis, and Servier. He is neither an employee nor a stock shareholder of any of these companies. Drs. Visser, Rommelse, Lappenschaar, Servatius-Oosterling, and Greven report no biomedical financial interests or potential conflicts of interest.


© 2017  American Academy of Child and Adolescent Psychiatry. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 56 - N° 8

P. 659-668 - août 2017 Retour au numéro
Article précédent Article précédent
  • Depression and Violence in Adolescence and Young Adults: Findings From Three Longitudinal Cohorts
  • Rongqin Yu, Mikko Aaltonen, Susan Branje, Tiina Ristikari, Wim Meeus, Katariina Salmela-Aro, Guy M. Goodwin, Seena Fazel
| Article suivant Article suivant
  • The Network Structure of Posttraumatic Stress Symptoms in Children and Adolescents Exposed to Disasters
  • Justin D. Russell, Erin L. Neill, Victor G. Carrión, Carl F. Weems

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.